Gamifant
List of products in the National Drug Code with proprietary name gamifant. This medication is used to treat a certain immune system problem (hemophagocytic lymphohistiocytosis - HLH).
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Labeler Name | Product Type |
|---|---|---|---|---|---|---|
| 66658-501 | Gamifant | Emapalumab-lzsg | Injection | Intravenous | Swedish Orphan Biovitrum Ab (publ) | Human Prescription Drug |
| 66658-505 | Gamifant | Emapalumab-lzsg | Injection | Intravenous | Swedish Orphan Biovitrum Ab (publ) | Human Prescription Drug |
| 66658-510 | Gamifant | Emapalumab-lzsg | Injection | Intravenous | Swedish Orphan Biovitrum Ab (publ) | Human Prescription Drug |
| 66658-522 | Gamifant | Emapalumab-lzsg | Injection | Intravenous | Swedish Orphan Biovitrum Ab (publ) | Human Prescription Drug |
| 66658-523 | Gamifant | Emapalumab-lzsg | Injection | Intravenous | Swedish Orphan Biovitrum Ab (publ) | Human Prescription Drug |
| 66658-524 | Gamifant | Emapalumab-lzsg | Injection | Intravenous | Swedish Orphan Biovitrum Ab (publ) | Human Prescription Drug |
| 66658-525 | Gamifant | Emapalumab-lzsg | Injection | Intravenous | Swedish Orphan Biovitrum Ab (publ) | Human Prescription Drug |